Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) announces the publication of the company's Annual Report and Annual Review for the fiscal year ended December 31, 2005. The report was made available on the company's website on March 3, 2006, with hard copies scheduled for distribution to shareholders and submission to the UK Listing Authority around March 23, 2006.
Key Financial Metrics
The filing text serves as a notification of publication and does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the linked Annual Report 2005 for these details.
Material Changes
No material changes or comparative financial data are disclosed within this specific filing text.
Guidance, Outlook, and Risks
This document contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It strictly confirms the availability of the 2005 Annual Report.
Investor Verification Checklist
- Verify the full text of the Annual Report 2005 on www.gsk.com for detailed financial performance.
- Confirm the date of the Annual General Meeting via the Notice of Annual General Meeting to be sent to shareholders.
- Review the UK Listing Authority submission status expected around March 23, 2006.